Combined phytohaemagglutinin and dianhydrodulcitol treatment of lymphocytic choriomeningitis virus infection in mice.
The course of intracerebral lymphocytic choriomeningitis (LCM) virus infection was studied in mice treated simultaneously with dianhydrodulcitol (DAD) and phytohaemagglutinin (PHA). Earlier experiments revealed that DAD decreased and PHA enhanced the cellular immune response of mice to LCM virus infection. On applying the treatments simultaneously they inhibited each other and neither the decreasing effect of DAD nor the enhancing effect of PHA on the cellular immune response could be observed.
D000818:Animals; D004195:Disease Models, Animal; D004376:Galactitol / Q000031:analogs & derivatives* / Q000494:pharmacology; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents; D007275:Injections, Intravenous; D037102:Lectins / Q000494:pharmacology*; D008216:Lymphocytic Choriomeningitis / Q000276:immunology*; D051379:Mice; D009929:Organ Size; D013154:Spleen / Q000276:immunology; D013402:Sugar Alcohols / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D037102:Lectins; D013402:Sugar Alcohols; D004376:Galactitol